Brief: Hcw Biologics Announces Initiation Of First-In-Human Clinical Trial To Evaluate Hcw9302 In An Autoimmune Disease
18/11/2025 12:32
HCW Biologics Inc HCWB.O: HCW BIOLOGICS ANNOUNCES INITIATION OF FIRST-IN-HUMAN CLINICAL TRIAL TO EVALUATE HCW9302 IN AN AUTOIMMUNE DISEASE Source text: ID:nGNX6tqfs2 Further company coverage: HCWB.O
Recent news on Hcw Biologics
See all newsBrief: Hcw Biologics Maintains Momentum Toward Completion Of Ind Application For Clinical Study To Evaluate Lead T-Cell Engager In Solid Tumors
Brief: HCW Biologics Registers Resale Of Up To 1.81 Mln Shares Of Common Stock By Selling Stockholder- SEC Filing
NASDAQ RESUMED AT 10:34 AM
NASDAQ TRADE HALT VOLATILITY TRADING PAUSE AT 10:29 AM
NASDAQ RESUMED AT 10:29 AM